Hereditary Hemorrhagic Telangiectasia (HHT) is easily recognized in individ
uals displaying the classical triad of epistaxis, telangiectasia, and a sui
table family history, but the disease is more difficult to diagnosis in man
y patients. Serious consequences may result if visceral arteriovenous malfo
rmations, particularly in the pulmonary circulation, are unrecognized and l
eft untreated. In spite of the identification of two of the disease-causing
genes (endoglin and ALK-1), only a clinical diagnosis of HHT can be provid
ed for the majority of individuals. On behalf of the Scientific Advisory Bo
ard of the HHT Foundation International, Inc., we present consensus clinica
l diagnostic criteria. The four criteria (epistaxes, telangiectasia, viscer
al lesions and an appropriate family history) are carefully delineated, The
HHT diagnosis is definite if three criteria are present. A diagnosis of HH
T cannot be established in patients with only two criteria, but should be r
ecorded as possible or suspected to maintain a high index of clinical suspi
cion. If fewer than two criteria are present, HHT is unlikely, although chi
ldren of affected individuals should be considered at risk in view of age-r
elated penetration in this disorder. These criteria may be refined as molec
ular diagnostic tests become available in the next few years. (C) 2000 Wile
y-Liss, Inc.